|
AP9528a-ev
|
Abcepta, Inc.
|
CHMP4B [N-term] [RB24088], Rabbit Polyclonal Antibody
|
Human
|
FC, IHC-P, WB
|
|
|
AP9528a
|
Abcepta, Inc.
|
CHMP4B [N-term] [RB24088], Rabbit Polyclonal Antibody
|
Human
|
FC, IHC-P, WB
|
|
|
ATGP0824-100ug
|
NKMax Bio (ATGen)
|
GRP78/HSPA5 [20-650 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
|
ATGP0824-500ug
|
NKMax Bio (ATGen)
|
GRP78/HSPA5 [20-650 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
|
BIP0901-100ug
|
NKMax Bio (ATGen)
|
GRP78/HSPA5 [20-650 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
|
BIP0901-500ug
|
NKMax Bio (ATGen)
|
GRP78/HSPA5 [20-650 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
|
ATGP3462-250ug
|
NKMax Bio (ATGen)
|
Iduronate 2-Sulfatase [26-550 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
|
ATGP3462-50ug
|
NKMax Bio (ATGen)
|
Iduronate 2-Sulfatase [26-550 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
|
HY-103332-10mg
|
MedChemexpress LLC
|
N-Arachidonylglycine [CAS 179113-91-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-103332-100mg
|
MedChemexpress LLC
|
N-Arachidonylglycine [CAS 179113-91-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-103332-25mg
|
MedChemexpress LLC
|
N-Arachidonylglycine [CAS 179113-91-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-103332-5mg
|
MedChemexpress LLC
|
N-Arachidonylglycine [CAS 179113-91-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-103332-50mg
|
MedChemexpress LLC
|
N-Arachidonylglycine [CAS 179113-91-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-114226-10mg
|
MedChemexpress LLC
|
Olutasidenib [CAS 1887014-12-1]
|
|
Cancer-programmed cell death
|
|
|
HY-114226-100mg
|
MedChemexpress LLC
|
Olutasidenib [CAS 1887014-12-1]
|
|
Cancer-programmed cell death
|
|
|
HY-114226-25mg
|
MedChemexpress LLC
|
Olutasidenib [CAS 1887014-12-1]
|
|
Cancer-programmed cell death
|
|
|
HY-114226-5mg
|
MedChemexpress LLC
|
Olutasidenib [CAS 1887014-12-1]
|
|
Cancer-programmed cell death
|
|
|
HY-114226-50mg
|
MedChemexpress LLC
|
Olutasidenib [CAS 1887014-12-1]
|
|
Cancer-programmed cell death
|
|
|
HY-114226-1mL
|
MedChemexpress LLC
|
Olutasidenib [CAS 1887014-12-1] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-10224-10mg
|
MedChemexpress LLC
|
Panobinostat [CAS 404950-80-7]
|
|
Cancer-programmed cell death
|
|
|
HY-10224-100mg
|
MedChemexpress LLC
|
Panobinostat [CAS 404950-80-7]
|
|
Cancer-programmed cell death
|
|
|
HY-10224-200mg
|
MedChemexpress LLC
|
Panobinostat [CAS 404950-80-7]
|
|
Cancer-programmed cell death
|
|
|
HY-10224-5mg
|
MedChemexpress LLC
|
Panobinostat [CAS 404950-80-7]
|
|
Cancer-programmed cell death
|
|
|
HY-10224-50mg
|
MedChemexpress LLC
|
Panobinostat [CAS 404950-80-7]
|
|
Cancer-programmed cell death
|
|
|
HY-10224-500mg
|
MedChemexpress LLC
|
Panobinostat [CAS 404950-80-7]
|
|
Cancer-programmed cell death
|
|
